HO-1 (E3F4S) Rabbit Monoclonal Antibody and 1 more item

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, awarded a purchase order (PO) to Cell Signaling Technology Inc., based in Boston, Massachusetts, for two specialized research-related monoclonal antibodies. The contract, identified as 4800167369, was issued on December 30, 2025, with a completion date of January 5, 2026. The procurement involves two distinct line items: a HO-1 (E3F4S) Rabbit Monoclonal Antibody priced at $153.00 and a HIF-1 alpha (D1S7W) Rabbit Monoclonal Antibody priced at $155.00, resulting in a total contract value of $308.00.

The purchase order stipulates delivery to UNMC Shipping and Receiving, with the specific unloading point designated as BCC 10.12.361. The transaction is governed by the University of Nebraska's standard purchase terms, with Net 30 payment conditions and F.O.B. destination shipping. The contract appears to be a targeted acquisition of research-grade antibodies, likely for scientific or medical research purposes, consistent with the medical center's academic and research mission. The order's modest value and specific technical specifications suggest a precise, targeted procurement to support ongoing research initiatives.